Investigating how inhibiting mTORC1 can improve lysosomal function in Alzheimer's disease
Modulating Alzheimer's Disease by mTORC1 inhibition to augment lysosomal activity
This study is looking at how blocking a specific protein can boost the cleaning process in brain cells, which might help us find new ways to slow down Alzheimer's disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11259043 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of mTORC1 inhibition in enhancing lysosomal activity, which may help in addressing the underlying mechanisms of Alzheimer's disease. The approach involves studying protein degradation and lysosomal function in neurodegeneration, utilizing advanced techniques such as in vitro tissue culture and mouse models. By exploring these mechanisms, the research aims to uncover new therapeutic strategies that could potentially slow down or alter the progression of Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias, particularly those experiencing symptoms related to protein aggregation.
Not a fit: Patients with early-stage cognitive impairment not yet diagnosed with Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve the quality of life for patients with Alzheimer's disease by targeting the disease's underlying biological processes.
How similar studies have performed: Previous research has shown promise in targeting lysosomal function and protein degradation pathways in neurodegenerative diseases, indicating that this approach may yield beneficial results.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Lear, Travis Bradley — Rutgers Biomedical and Health Sciences
- Study coordinator: Lear, Travis Bradley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.